App-Quantinova.ai

Gdf-5 Deficiency Prevents Cardiac Rupture Following Acute Myocardial Infarction in Mice

Eric Shikatani - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Recruitment of Pro-Inflammatory Ly6ChighCCR2+ Monocytes to the Myocardium is Critical to the Development of Hypertension Related Myocardial Fibrosis

Alec Falkenham - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial fibrosis

Angiotensin II

Oxldl-derived Lysophosphatidic Acid Generates a Nf-?B Signature Through Lpar1 That Promotes the Progression of Aortic Valve Stenosis

Marie Chloe Boulanger - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic stenosis

N/A

The Pro-Hypertrophic High Molecular Weight Fgf2 Activates Ampk or Erk by Engaging, Respectively, Fgfr1-Independent or Fgfr1-Dependent Pathways

Barbara E Nickel - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hypertrophic cardiomyopathy

Doxorubicin

Crystallized Iron Deposits From Hemorrhagic Myocardial Infarctions Promote Macrophage Polarization Preferentially to a Pro-Inflammatory, M1, Phenotype within Chronic Myocardial Infarcts

Avinash Kali - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Intermittent Pre-excitation in Wolff Parkinson White Syndrome Does Not Convey Low Risk

Kathryn K Collins - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Isoproterenol

MicroRNA Sequencing Highlights Regulatory Networks Upstream of Osteopontin and B-type Natriuretic Peptide in Acute Coronary Sydrome

Elizabeth Grass - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

N/A

Time-dependent Association of Circulating microRNAs With Death and Myocardial Infarction After Non-ST Elevation Acute Coronary Syndrome

Megan L. Neely - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Whole-genome microRNA Sequencing Reveals Circulating microRNAs as High-Risk Markers in Non-ST-Elevation Acute Coronary Syndrome

Lydia Coulter-Kwee - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

Grace

Conductive Biomaterial Enhanced Electrical Propagation Across a Left Ventricular Scar After a Myocardial Infarction

Jun Wu - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Ventricular arrhythmias

chitosan

MicroRNA 145 Prevents Infarct Scar Expansion and May be a New Target for Cardiac Restoration After Myocardial Infarction

Sheng He - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

A Conductive Biomaterial Patch to Repair a Cardiac Defect

Hui-Fang Song - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

chitosan

Cycloxygenase 2 Preserves Immunoprivilege of Allogeneic Mesenchymal Stem Cells in the Ischemic Heart

Ejlal Abu-El Rub - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Dinoprostone

Endothelial-specific Loss of Primary Cilia Exacerbates Cardiac Fibrosis

Pratiek N Matkar - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac fibrosis

N/A

Local Production of Interleukin-33 and its Ability to Activate Mast Cells to Produce Pro-fibrotic Mediators May be Associated With Cardiac Fibrosis

Jean S Marshall - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial injury

Interleukin

IMPROVEDD Score: Addition of D-Dimer to the IMPROVE Score Improves Venous Thromboembolism Risk Stratification. An APEX Trial Substudy

Gerald Chi - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

International Calmodulinopathy Registry (ICaMR)

Carla Spazzolini - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Catecholaminergic polymorphic ventricular tachycardia

Mexitil

Adherence to the 2012 Canadian Lipid Screening Guidelines in Primary Prevention Patients: The CANHEART Study

Anna Chu - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Dyslipidemia

N/A

ICD Lead Performance in Athletes: Long-term Results of a Prospective Multinational Registry

Brian Olshansky - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Structural Heart Disease

N/A

Are We There Yet? Dissipating Sex Differences in Acute Coronary Syndromes. A Population Level Examination

Anamaria Savu - American Heart Association (AHA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Filters

28841 Abstracts